RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Irritable Bowel Syndrome Therapy Area Pipeline Report
Nov 2010 - 220 pages - $1,495
Gastrointestinal Drug Discoveries
Jan 2008 - 148 pages - $1,740
Irritable Bowel Syndrome (IBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sep 2011 - 94 pages - $3,500
Irritable Bowel Syndrome - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 54 pages - $2,000
Irritable Bowel Syndrome - Pipeline Review, Q1 2011
Feb 2011 - 67 pages - $500
The World Market for Prescription Gastrointestinal Drugs
Jul 2006 - 240 pages - $3,500
Irritable Bowel Syndrome - Pipeline Review, H2 2011
Sep 2011 - 134 pages - $500
Short Bowel Syndrome - Pipeline Review, Q2 2011
May 2011 - 35 pages - $500
The Gastrointestinal Market Outlook to 2016
Aug 2011 - 81 pages - $3,835
Irritable Bowel Syndrome Global Clinical Trials Review, Q4, 2010
Dec 2010 - 72 pages - $1,000
More Related Market Research Reports >>>

Your selection

Therapeutic target
Gastrointestinal del
Irritable bowel syndrome del
Development phase
Phase III/IV del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us